Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

1.

Genetic markers of malignant transformation in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis.

Nissim S, Idos GE, Wu B.

Pancreas. 2012 Nov;41(8):1195-205. doi: 10.1097/MPA.0b013e3182580fb4.

2.

Mucinous cystic neoplasm (mucinous cystadenocarcinoma of low-grade malignant potential) of the pancreas: a clinicopathologic study of 130 cases.

Thompson LD, Becker RC, Przygodzki RM, Adair CF, Heffess CS.

Am J Surg Pathol. 1999 Jan;23(1):1-16.

PMID:
9888699
3.

Malignant transformation of branch duct-type intraductal papillary mucinous neoplasms of the pancreas based on contrast-enhanced endoscopic ultrasonography morphological changes: focus on malignant transformation of intraductal papillary mucinous neoplasm itself.

Ohno E, Itoh A, Kawashima H, Ishikawa T, Matsubara H, Itoh Y, Nakamura Y, Hiramatsu T, Nakamura M, Miyahara R, Ohmiya N, Ishigami M, Katano Y, Goto H, Hirooka Y.

Pancreas. 2012 Aug;41(6):855-62. doi: 10.1097/MPA.0b013e3182480c44.

PMID:
22481289
4.

Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules.

Sadakari Y, Ienaga J, Kobayashi K, Miyasaka Y, Takahata S, Nakamura M, Mizumoto K, Tanaka M.

Pancreas. 2010 Mar;39(2):232-6. doi: 10.1097/MPA.0b013e3181bab60e.

PMID:
19752768
5.

Predictors of malignant intraductal papillary mucinous neoplasm of the pancreas.

Mimura T, Masuda A, Matsumoto I, Shiomi H, Yoshida S, Sugimoto M, Sanuki T, Yoshida M, Fujita T, Kutsumi H, Ku Y, Azuma T.

J Clin Gastroenterol. 2010 Oct;44(9):e224-9. doi: 10.1097/MCG.0b013e3181d8fb91.

PMID:
20453661
6.

Malignant potential of solid pseudopapillary neoplasm of the pancreas.

Tipton SG, Smyrk TC, Sarr MG, Thompson GB.

Br J Surg. 2006 Jun;93(6):733-7.

PMID:
16609955
7.

Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors.

Hirono S, Tani M, Kawai M, Ina S, Nishioka R, Miyazawa M, Fujita Y, Uchiyama K, Yamaue H.

Arch Surg. 2009 Apr;144(4):345-9; discussion 349-50. doi: 10.1001/archsurg.2009.2.

PMID:
19380648
8.

Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary-mucinous neoplasm of the pancreas.

Tomimaru Y, Takeda Y, Tatsumi M, Kim T, Kobayashi S, Marubashi S, Eguchi H, Tanemura M, Kitagawa T, Nagano H, Umeshita K, Wakasa K, Doki Y, Mori M.

Oncol Rep. 2010 Sep;24(3):613-20.

PMID:
20664965
9.

Malignant serous cystic neoplasm of the pancreas: report of a case and review of the literature.

Matsumoto T, Hirano S, Yada K, Shibata K, Sasaki A, Kamimura T, Ohta M, Kitano S, Kashima K.

J Clin Gastroenterol. 2005 Mar;39(3):253-6. Review.

PMID:
15718870
10.

Synchronous and metachronous extrapancreatic malignant neoplasms in patients with intraductal papillary-mucinous neoplasm of the pancreas.

Ishida M, Egawa S, Kawaguchi K, Aoki T, Sakata N, Mikami Y, Motoi F, Abe T, Fukuyama S, Katayose Y, Sunamura M, Unno M, Moriya T, Horii A, Furukawa T.

Pancreatology. 2008;8(6):577-82. doi: 10.1159/000159844. Epub 2008 Sep 29.

PMID:
18824881
11.

Intraductal papillary mucinous neoplasm of the pancreas: can benign lesions be differentiated from malignant lesions with multidetector CT?

Kawamoto S, Horton KM, Lawler LP, Hruban RH, Fishman EK.

Radiographics. 2005 Nov-Dec;25(6):1451-68; discussion 1468-70. Review.

PMID:
16284127
12.

Mucinous cystic neoplasm of the pancreas with neuroendocrine cells and malignant stroma.

Asberry DE, Youngberg GA, Al-Abbadi MA.

Saudi Med J. 2013 Jan;34(1):80-5.

PMID:
23299164
13.

Synchronous extrapancreatic malignant papillary mucinous neoplasms in a patient with intraductal papillary mucinous neoplasm of the pancreas: a rare case of simultaneous pancreatic, hepatic, and pulmonary involvement.

Tarantino I, Mocciaro F, Barresi L, Vitulo P, Liotta R, Curcio G, Granata A, Pisa MD, Traina M.

Pancreas. 2012 Apr;41(3):501-2. doi: 10.1097/MPA.0b013e3182320bf7. No abstract available.

PMID:
22415674
14.

Malignant intraductal papillary mucinous neoplasm of the pancreas: in situ versus invasive carcinoma surgical resectability.

Vullierme MP, Giraud-Cohen M, Hammel P, Sauvanet A, Couvelard A, O'Toole D, Levy P, Ruszniewski P, Vilgrain V.

Radiology. 2007 Nov;245(2):483-90. Epub 2007 Sep 11.

PMID:
17848678
15.

Risk of malignant neoplasm of the pancreas in relation to diabetes: a population-based study in Taiwan.

Chen HF, Chen P, Li CY.

Diabetes Care. 2011 May;34(5):1177-9. doi: 10.2337/dc10-2006. Epub 2011 Mar 11.

16.

[Solid pseudopapillary tumor of the pancreas: a neoplasm of low malignant potential?].

Reaño G, De Vinatea J, Kometter F, Villanueva L, Gonzáles E, Uribe M, Tang J, Casas G, Robledo H, Arenas J.

Rev Gastroenterol Peru. 2011 Jan-Mar;31(1):61-71. Spanish.

PMID:
21544158
17.

Differential diagnosis of benign or malignant intraductal papillary mucinous neoplasm of the pancreas by multidetector row helical computed tomography: evaluation of predictive factors by logistic regression analysis.

Takeshita K, Kutomi K, Takada K, Haruyama T, Fukushima J, Aida R, Takada T, Furui S.

J Comput Assist Tomogr. 2008 Mar-Apr;32(2):191-7. doi: 10.1097/RCT.0b013e3180676d97.

PMID:
18379300
18.

Invaginated ampulla of Vater in synchronous malignant intraductal papillary mucinous neoplasm of the pancreas and common bile duct cancer.

Han JW, Jang SI, Ma DW, Yoon SO, Lee DK.

Endoscopy. 2013;45 Suppl 2 UCTN:E25-6. doi: 10.1055/s-0032-1326106. Epub 2013 Mar 6. No abstract available.

PMID:
23468151
19.
20.

The malignant nature of papillary and cystic neoplasm of the pancreas.

Sclafani LM, Reuter VE, Coit DG, Brennan MF.

Cancer. 1991 Jul 1;68(1):153-8. Review.

Supplemental Content

Support Center